Republican Representative Diana Harshbarger of Tennessee, a pharmacist by training, has introduced legislation that would compel health insurance companies offering coverage for transgender procedures to also pay for detransition care and treatment for adverse effects. The bill, known as the TRUTH in Coverage Act, targets what Harshbarger describes as a financial one-way door that leaves patients who regret sex-reassignment procedures without coverage for restorative care.
Harshbarger argued that current insurance practices are unfair to patients seeking to reverse or manage the consequences of such procedures. «It's outrageous that a health plan can cover sex-rejecting procedures but refuse to cover the restorative care patients need to address the harm they cause,» she said. «That's not a fair deal for patients who want to restore healthy bodily function.» The lawmaker, who has a background in pharmacy, emphasized that insurers often find excuses to deny necessary care, and her bill aims to restore fairness and transparency.
The TRUTH in Coverage Act would amend three federal statutes governing private health insurance: the Public Health Service Act, employer-sponsored health plans, and group health plans. It would require insurers that cover what the bill terms «sex-rejecting procedures» to also cover items and services needed to address complications or adverse effects resulting from those procedures. The requirement would apply regardless of state or local laws that mandate such procedures, creating a uniform federal standard. If passed, the bill would take effect on January 1, 2027, and would prevent insurers from adjusting copays, deductibles, or implementing treatment limitations for the covered care.
The legislation has attracted 12 cosponsors, including Representative Buddy Carter of Georgia, a former chairman of the Energy and Commerce Subcommittee on Health. Despite this support, the bill faces significant obstacles in the Senate, where Democratic opposition makes passage unlikely in the current political climate. Nevertheless, its introduction draws attention to a growing number of patients who have regretted sex-reassignment procedures and the barriers they face in addressing the fallout.
The issue of detransition has gained traction at the state level as well. Texas Governor Greg Abbott signed a similar bill into law last year, addressing the same concern locally. Texas Senator Bryan Hughes, who sponsored Senate Bill 1257, published a statement arguing that many individuals who undergo transgender procedures require extensive medical care to manage or reverse the effects of previous treatments but are frequently denied insurance coverage. «Without this coverage, patients face significant health risks, including hormone imbalances, surgical complications, and psychological distress,» Hughes wrote.
Determining the exact number of detransitioners is challenging, according to the National Library of Medicine. Researchers note that stopping hormones, reversing surgeries, or changing legal documents could all be triggers for beginning the detransition process. By casting a wide net and including adverse effects, Harshbarger's bill would circumvent these technicalities, ensuring that patients are not abandoned after undergoing life-altering medical interventions. «Patients should never be abandoned after undergoing life-altering, harmful medical interventions once reality sets in,» Harshbarger said.
The bill's prospects remain uncertain, with no clear timeline for a House floor vote. However, its introduction signals growing lawmaker concern over the long-term consequences of transgender procedures and the financial and medical burdens placed on patients who seek to reverse them. As the debate continues, the TRUTH in Coverage Act highlights a contentious intersection of healthcare policy, insurance regulation, and patient rights.
